Management of Severe Agitation in Grade III-IV Hepatic Encephalopathy
Airway Protection and Initial Management
- Immediately perform endotracheal intubation for airway protection in all patients with grade III-IV encephalopathy, as these patients are at high risk for aspiration and loss of protective reflexes 1
- Elevate the head to 30 degrees to reduce intracranial pressure 1
- Diuretic therapy is generally not recommended in patients with persistent overt hepatic encephalopathy 2
Sedation and Antipsychotic Use
- The American College of Physicians recommends minimizing or avoiding sedatives in hepatic encephalopathy because they interfere with neurological assessment, have delayed clearance in liver failure, and can worsen or mask the underlying encephalopathy 3
- Propofol in small doses is the preferred sedative if sedation is absolutely necessary, as it may reduce cerebral blood flow 1
- Haloperidol 5 mg IM achieved mean sedation time of 28.3 minutes in agitated patients 4
- The combination of haloperidol (10 mg) with promethazine (25-50 mg) has been studied specifically for agitation in psychiatric emergency settings, with 96% of patients achieving tranquility or sleep within 4 hours 5
Monitoring and Safety Considerations
- Perform frequent neurological evaluations for signs of intracranial hypertension 1
- Monitor for infection as a cause of deterioration 1
- Maintain close surveillance of hemodynamic parameters, renal function, glucose, and electrolytes 1
- Emergency equipment and reversal agents must be readily available 3
Treatment of Seizures and Intracranial Hypertension
- Seizures should be treated with phenytoin as first-line, not sedation 6
- Intracranial hypertension requires mannitol (0.5-1 g/kg bolus), not sedation 1
Management of Agitation in Hepatic Encephalopathy
First-Line Pharmacological Management
- The American Association for the Study of Liver Diseases recommends haloperidol 0.5-5 mg PO/IM every 8-12 hours for mild to moderate agitation in patients with hepatic encephalopathy 7, 8, 9
Critical Medications to Avoid
- The European Society of Anaesthesiology advises against the use of benzodiazepines in hepatic encephalopathy due to their delayed clearance and potential to worsen encephalopathy 10
- A meta-analysis of 8 RCTs (n=736 patients) showed that flumazenil lowered encephalopathy scores, suggesting a deleterious effect of benzodiazepines in this population, as reported by the Anaesthesia journal 10